Thrivent Financial for Lutherans’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-205,243
| Closed | -$6.96M | – | 2553 |
|
|
2024
Q2 | $6.96M | Sell |
205,243
-8,747
| -4% | -$296K | 0.01% | 778 |
|
|
2024
Q1 | $13.9M | Buy |
213,990
+2,159
| +1% | +$140K | 0.03% | 559 |
|
|
2023
Q4 | $14.5M | Sell |
211,831
-4,094
| -2% | -$280K | 0.03% | 520 |
|
|
2023
Q3 | $11.2M | Buy |
215,925
+2,842
| +1% | +$147K | 0.03% | 574 |
|
|
2023
Q2 | $12.8M | Sell |
213,083
-3,974
| -2% | -$238K | 0.03% | 564 |
|
|
2023
Q1 | $10.7M | Buy |
217,057
+3,289
| +2% | +$163K | 0.03% | 596 |
|
|
2022
Q4 | $12.2M | Buy |
213,768
+3,897
| +2% | +$222K | 0.03% | 546 |
|
|
2022
Q3 | $9.85M | Sell |
209,871
-159,633
| -43% | -$7.49M | 0.03% | 593 |
|
|
2022
Q2 | $13.8M | Sell |
369,504
-18,190
| -5% | -$679K | 0.04% | 503 |
|
|
2022
Q1 | $11.6M | Buy |
387,694
+32,611
| +9% | +$975K | 0.02% | 636 |
|
|
2021
Q4 | $12.2M | Buy |
355,083
+4,869
| +1% | +$167K | 0.02% | 620 |
|
|
2021
Q3 | $13M | Buy |
350,214
+1,400
| +0.4% | +$51.9K | 0.03% | 598 |
|
|
2021
Q2 | $13.6M | Buy |
348,814
+28,562
| +9% | +$1.12M | 0.03% | 592 |
|
|
2021
Q1 | $13.6M | Buy |
+320,252
| New | +$13.6M | 0.03% | 574 |
|